R&F Capital Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

R&F Capital Advisors’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$119K	Buy	+514	New	+$88.8K	0.03%	602

Other funds holding CALA

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

R&F Capital Advisors's CALA Position: Q1 2017 in Review

R&F Capital Advisors opened a new position in Calithera Biosciences, Inc (CALA) in Q1 2017: 514 shares worth $119K. The stake represents 0.03% of the portfolio and ranks #602 among its holdings.

74 funds tracked by Wall St. Rank hold CALA as of Q1 2017.

R&F Capital Advisors held 514 shares of Calithera Biosciences, Inc worth $119K as of Q1 2017.
Calithera Biosciences, Inc was a new R&F Capital Advisors position in Q1 2017.
Calithera Biosciences, Inc made up 0.03% of R&F Capital Advisors's portfolio in Q1 2017, its #602 holding.
74 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2017.

Based on R&F Capital Advisors's 13F filing for Q1 2017, filed 15 May 2017.